Skip to main content
. 2018 Dec 27;5(3):376–383. doi: 10.1001/jamaoncol.2018.5860

Figure 1. Progression-Free Survival and Overall Survival Among Patients With or Without Immune-Related Adverse Events (irAEs).

Figure 1.

Kaplan-Meier curves are shown for progression-free survival (A) and overall survival (B) among patients with (irAE+) or without irAEs (irAE). Tick marks indicate patients for whom data were censored on May 10, 2018.